Elsevier Global Medical News. 2010 Jul 26, R FINN
Patients newly diagnosed with prostate cancer who have a prostate specific antigen levels of 4.0 ng/mL or below tend to receive aggressive therapy despite having a low risk of disease, according to a retrospective study of 123,934 men in the July 26 issue of the Archives of Internal Medicine...
Žádné komentáře:
Okomentovat
Poznámka: Komentáře mohou přidávat pouze členové tohoto blogu.